EyeGate Pharma Acquires Jade Therapeutics
Transaction enhances development pipeline with addition of new ophthalmic platform technology. First Jade product to enter clinic later this year. WALTHAM, Mass., March 07, 2016 (GLOBE NEWSWIRE) -- Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or …